**Specifications Table**TableSubject areaBiologyMore specific subject areaBacterial metagenomicsType of dataText files: sequencesHow data was acquiredDNA sequencing using Illumina HiSeq 2500 platformData formatRawExperimental factorsDNA extracted from stool samplesExperimental featuresTwo micrograms of total DNA per sample were used to create barcoded paired-end sequencing libraries. "Shotgun" sequencing was performed using Illumina HiSeq 2500 platform according to the recommendations of the manufacturer.Data source locationKazan, Russian FederationData accessibilityThe data is deposited in the European Nucleotide Archive (project ID: PRJEB18265, URL: <http://www.ebi.ac.uk/ena/data/view/PRJEB18265>).

**Value of the data**•The data can be used to assess the antibiotic-induced gut dysbiosis in a cultivation-independent manner via the changes in the relative abundance of microbial taxa and genes.•Using the metagenomic datasets corresponding to three consequent time points - before, immediately after and 1 month after the end of the treatment - it is possible to analyze the temporal dynamics and resilience of gut microbial ecosystem.•By calculating the relative abundance of the genes conferring antibiotic resistance from the data, researchers can evaluate the resistome of gut microbiota and its changes during and after the antibiotic intake.•Identification of specific changes in gut microbiota composition as the result of *H. pylori* eradication using the presented data opens the way to designing new approaches to the alleviation of the side effects of the treatment.

1. Data {#s0005}
=======

The presented dataset contains 10 "shotgun" human gut metagenomes assessed from stool samples from the patients with *Helicobacter pylori* infection. The total read length for the dataset is 87.6 Gbp (the metagenomes contain 34.1±13.6 mln of reads per sample, mean±s.d.). Details about the dataset are shown in [Table 1](#t0005){ref-type="table"}.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Cohorts assembly {#s0015}
---------------------

The study was approved by the Local ethics committee of the Kazan (Volga region) Federal University. Each patient signed an informed consent before the start of the study. The patients were enrolled in University Hospital of Kazan Federal University (former Republican Clinical Hospital \#2 of the Ministry of Healthcare of Republic of Tatarstan).

2.2. Patients inclusion and exclusion criteria {#s0020}
----------------------------------------------

General inclusion criteria: males and females, age 18--75 years with performed upper GI endoscopy and *H. pylori*-positive status 1 month prior to the inclusion into the study (according to any of the *H. pylori* detection methods). Exclusion criteria: malignancies; inability of the patient to follow the study procedures; concomitant diseases possibly influencing the gut microbiota composition including inflammatory bowel diseases, malabsorption (due to small intestine diseases or pancreatic insufficiency) and other diseases; abdominal surgery (excluding appendectomy); intake of medications (immunomodulators, corticosteroids, non-steroidal anti-inflammatory drugs, antibiotics, pre- and probiotics - for 3 months prior to the inclusion; proton pump inhibitors, bismuth-containing medications - for 2 weeks prior to inclusion); alcohol or drug abuse; decompensated chronic diseases; infectious diseases including HIV, viral hepatitis, tuberculosis and others; presence of diarrhea (bowel movement frequency \>3 times a day) for at least 3 consequent days during the last month; pregnancy or breastfeeding.

2.3. Sample collection and metagenomic sequencing {#s0025}
-------------------------------------------------

Stool samples were collected from the subjects, stored and subject to DNA extraction as described before [@bib1]. Barcoded paired-end libraries were created from 2 μg of total DNA for each sample according to the manufacturer׳s recommendations using NEBNext DNA Library Prep Master Mix Set for Illumina (New England Biolabs, USA) and NEBNext Multiplex Oligos for Illumina (96 Index Primers) (New England Biolabs, USA) kits. "Shotgun" metagenomic sequencing was performed on HiSeq 2500 platform (Illumina, USA) according to the manufacturer׳s recommendations using the following reagent kits: HiSeq Rapid PE Cluster Kit v2, HiSeq Rapid SBS Kit v2 (500 cycles), HiSeq Rapid PE FlowCell v2. The resulting read length was 250 bp.
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=============================================

Supplementary material.

This work was financially supported by Russian Scientific Foundation (project ID 15-14-00066).

Transparency data associated with this article can be found in the online version at [doi:10.1016/j.dib.2017.01.007](http://dx.doi.org/10.1016/j.dib.2017.01.007){#ir0010}.

###### 

**Description of the metagenomic datasets**. In "Time point" column, the numbers show the point of sample collection: 1 - before the treatment, 2 - immediately after the end of the treatment, 3 - one month after the end of the treatment. Abbreviations: ENA -- European Nucleotide Archive, BMI - body-mass index. The patients for whom the samples were collected at three time points include P3 and P4.

Table 1

  **Sample ID**   **ENA sample number**   **ENA experiment number**   **Time point**   **Internal patient ID**   **Gender**   **Age**   **BMI**
  --------------- ----------------------- --------------------------- ---------------- ------------------------- ------------ --------- ---------
  Hp_21_S2        ERS1462079              ERX1813428                  1                P1                        M            31        28.07
  Hp_22_S23       ERS1462080              ERX1813429                  2                                                                 
  Hp_23_S25       ERS1462081              ERX1813430                  1                P2                        F            63        27.39
  Hp_24_S11       ERS1462082              ERX1813431                  2                                                                 
  Hp_5\_S19       ERS1462083              ERX1813432                  1                P3                        F            31        18.49
  Hp_6\_S28       ERS1462084              ERX1813433                  2                                                                 
  Hp_7\_S14       ERS1462088              ERX1813437                  3                                                                 
  Hp_73_S10       ERS1462085              ERX1813434                  1                P4                        M            54        24.06
  Hp_74_S4        ERS1462086              ERX1813435                  2                                                                 
  Hp_76_S8        ERS1462087              ERX1813436                  3                                                                 
